Indonesia’s First Publication of Botulinum Toxin Guidelines Launched
The first publication of Botulinum Toxin Injection Guidelines in Indonesia is introduced by Indonesian Cosmetic Dermatology Study Group (KSDKI) which is part of Indonesian Association of Dermatologists and Venereologists (Perdoski). These guidelines are aimed at aesthetic practitioners so that they can provide the best and safest services to patients.
Botulinum Toxin injection, which has been on the market since 1999, is itself a world-famous aesthetic procedure for treating various medical conditions including leg stiffness and neck dystonia.
The expansion of off-label indications and the growing number of patients seeking aesthetic treatments have led to an increase in the use of Botulinum Toxin globally. In Indonesia particularly, positive growth of Botulinum Toxin is predicted to continue as the younger generation becomes more aware of getting aesthetic treatments.
The temporary results of Botulinum Toxin treatment may diminish over time. Therefore, repeated injections are required to maintain the effect of the treatment.
Aesthetic practitioners have been using Western guidelines that have been set for the use of Botulinum Toxin. However, everyone, especially in Indonesia, has a unique facial anatomy that varies. In addition, they also have different Botulinum Toxin treatment needs.
For this reason, the Botulinum Toxin Injection Manual is intended to expand the knowledge of aesthetic practitioners about clinical techniques in injection, indications, procedures, contraindications, immunogenicity, and side effects of Botulinum Toxin.
Immunogenicity relates to the reduction or absence of a therapeutic effect after successful initial treatment. Repeated injection of Botulinum Toxin will stimulate antibody formation; including neutralizing antibodies (NAbs) against their biological activity.
Dr. Lilik Norawati, Sp.KK, FINSDV, FAADV as Head of Indonesian Cosmetic Dermatology Study Group (KSDKI), explains that previously there were no guidelines for the management of Botulinum Toxin injection in Indonesia. To create a guideline that is fully supported by Merz Aesthetics, KSDKI gathered experts in the field of cosmetic dermatology.
“Hopefully, along with the creation of this guideline, it can provide great benefits for cosmetic dermatology practitioners so that they can prevent side effects and complications,” adds Dr. Lilik.
The trend of aesthetic treatments using Botulinum Toxin tends to increase in Indonesia. Thus, it is important for aesthetic practitioners to carry out a thorough clinical assessment and inform patients about the risks of treatment.
These guidelines also serve to develop a Botulinum Toxin treatment plan so that immune resistance can be minimized. In addition, practitioners can use these guidelines to maintain the choice of Botulinum Toxin as a follow-up treatment with satisfactory results.
“We support by launching the first Botulinum Toxin Injection Guidelines in Indonesia with Indonesian Cosmetic Dermatology Study Group (KSDKI), Merx Aesthetics’s Representave says.
Merz Aesthetics ensures that in addition to its products that always meet safety and quality standards including high effectiveness, it also provides Continuing Education support for doctors and increase awareness and education about the latest aesthetic products.
